Mitchell Essex (COO) sold 24.9K HOLX shares at $76.34 for $1.9M; holdings drop 47.1% to 28.0K shares.
Mitchell Essex, Chief Operating Officer of Hologic, executed a substantial open-market sale of 24,856 shares at $76.34 on 2024-12-04, reducing his holdings by 47.1% from 52.8K to 28.0K shares. The stock has since declined 6.4% over 30 days and 7.6% over 90 days, trading 10.0% below its 52-week high of $83.72. His prior sale at this ticker in November 2023 followed a similar negative subsequent pattern (+2.7% at 90 days, technically positive but not a clear signal). The company generates $1.0B in quarterly revenue with $194.5M in net income, valuing it at $17.1B with a P/E of 16.52. The magnitude of the reduction—nearly half his position—merits monitoring but lacks sufficient pattern data to characterize timing precision.